UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

Journal of clinical oncology, 2022-01, Vol.40 (2), p.202-212

2022

Volltextzugriff (PDF)

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

Leukemia & lymphoma, 2021-01, Vol.62 (1), p.58-67

2021

Volltextzugriff (PDF)

Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma

The oncologist (Dayton, Ohio), 2017-05, Vol.22 (5), p.549-553

2017

Volltextzugriff (PDF)

Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial

Clinical lymphoma, myeloma and leukemia, 2015-03, Vol.15 (3), p.152-158

2015

Volltextzugriff (PDF)

Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review

Clinical lymphoma, myeloma and leukemia, 2016-03, Vol.16 (3), p.122-128

2016

Volltextzugriff (PDF)

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

Oncology (Williston Park, N.Y.), 2007-04, Vol.21 (4), p.434

Hagemeister, Fredrick B

2007

Volltextzugriff (PDF)

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

Leukemia & lymphoma, 2012-05, Vol.53 (5), p.801-806

2012

Volltextzugriff (PDF)

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

Cancer, 2005-07, Vol.104 (2), p.345-353

2005

Volltextzugriff (PDF)

Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapy

International journal of radiation oncology, biology, physics, 2003, Vol.55 (1), p.36-43

2003

Volltextzugriff (PDF)

Second malignancies after chemotherapy and radiotherapy for Hodgkin disease

American journal of clinical oncology, 2004-02, Vol.27 (1), p.73-80

2004

Volltextzugriff (PDF)

Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

Investigational new drugs, 1999-05, Vol.17 (2), p.187-192

1999

Volltextzugriff (PDF)

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Seminars in oncology, 2000-12, Vol.27 (6 Suppl 12), p.37

2000

Volltextzugriff (PDF)

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Journal of clinical oncology, 1997-12, Vol.15 (12), p.3488-3495

1997

Volltextzugriff (PDF)

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Journal of clinical oncology, 1994-03, Vol.12 (3), p.575-579

1994

Volltextzugriff (PDF)

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Journal of clinical oncology, 1990-04, Vol.8 (4), p.615-622

1990

Volltextzugriff (PDF)

Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 1997, Vol.26 (1-2), p.77-82

1997

Volltextzugriff (PDF)

NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease

Seminars in oncology, 1990-12, Vol.17 (6 Suppl 10), p.34

1990

Volltextzugriff (PDF)

A New Chemotherapy Regimen for Treatment of Hodgkin's Disease Associated with Minimal Genotoxicity

Leukemia & lymphoma, 1993, Vol.9 (6), p.503-508

1993

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaAntineoplastic Combined Chemotherapy Protocols - Adverse Effects

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Male
(14)
Adult
(13)
Female
(12)
Middle Aged
(12)
Aged
(11)
Mitoxantrone - Administration & Dosage
(8)
Hematology
(7)
Hodgkin Disease - Drug Therapy
(7)
Treatment Outcome
(7)
Biological And Medical Sciences
(6)
Chemotherapy
(6)
Medical Sciences
(6)
Neoplasm Staging
(6)
Aged, 80 And Over
(5)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma

Pegylated Liposomal Doxorubicin Replacing Conventional Doxorubicin in Standard R-CHOP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma: An Open Label, Single Arm, Phase II Trial

Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

Analysis of in-field control and late toxicity for adults with early-stage hodgkin’s disease treated with chemotherapy followed by radiotherapy

Second malignancies after chemotherapy and radiotherapy for Hodgkin disease

Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma

NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease

A New Chemotherapy Regimen for Treatment of Hodgkin's Disease Associated with Minimal Genotoxicity

Aktive Filter

Suchergebnisse filtern